Logo
x

Search

Subscribe Now

Tuberculosis

BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022

BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022

  • July 27, 2021
Gates Foundation Forms an Alliance with Global Pharma Companies to Develop PAN-TB Drug Regimen for Tuberculosis

Gates Foundation Forms an Alliance with Global Pharma Companies to Develop PAN-TB Drug Regimen for Tuberculosis

  • February 28, 2020
GSK Out Licenses its Tuberculosis Vaccine (M72/AS01E ) to Bill & Melinda Gates Medical Research Institute

GSK Out Licenses its Tuberculosis Vaccine (M72/AS01E ) to Bill & Melinda Gates Medical Research Institute

  • January 28, 2020
BioNTech Signs an Agreement with Gates Foundation to Develop Therapies for HIV and Tuberculosis

BioNTech Signs an Agreement with Gates Foundation to Develop Therapies for HIV and Tuberculosis

  • September 5, 2019
TB Alliance's Pretomanid Combination Therapy Receives the US FDA's Approval for Highly Drug-Resistant Forms of Tuberculosis

TB Alliance's Pretomanid Combination Therapy Receives the US FDA's Approval for Highly Drug-Resistant Forms of Tuberculosis

  • August 15, 2019
Roche Launches Cobas MTB-RIF/INH Test for the Detection of Antimicrobial Resistance in Tuberculosis

Roche Launches Cobas MTB-RIF/INH Test for the Detection of Antimicrobial Resistance in Tuberculosis

  • May 14, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.